U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
176941176941Tamsulosin Phase III Clinical Trial -Double-Blind, Placebo Controlled Study in Male Patients With Lower Urinary Tract SyndromeCompletedNo Results AvailableUrinary Tract DiseasesDrug: Tamusulosinhttps://ClinicalTrials.gov/show/NCT00239317
176942176942Gefitinib (Iressa) in Combo With Chemoradiation in Patients With Locally Advanced Head & Neck CancerCompletedNo Results AvailableHead and Neck NeoplasmsDrug: Gefitinib|Drug: Cisplatin|Procedure: Radiotherapyhttps://ClinicalTrials.gov/show/NCT00239304
176943176943Safety Study to Explore Combination of Gefitinib (ZD1839, Iressa) and Radiotherapy in Non-Metastatic Prostate CancerCompletedNo Results AvailableNon-Metastatic Prostate CancerDrug: Gefitinib, radiotherapyhttps://ClinicalTrials.gov/show/NCT00239291
176944176944Budesonide / Formoterol in Treatment of Exacerbations of COPDCompletedNo Results AvailableChronic Obstructive Pulmonary DiseaseDrug: budesonide/formoterol, 2x 200/6 microgram. 4 times daily|Drug: prednisolone, 30 mg once daily and placebohttps://ClinicalTrials.gov/show/NCT00239278
176945176945Tamsulosin Phase III Clinical Trial -Double-Blind, Placebo Controlled Study in Female Patients With Lower Urinary Tract SyndromeCompletedNo Results AvailableUrinary Tract DiseasesDrug: Tamuslosinhttps://ClinicalTrials.gov/show/NCT00239265
176946176946Comparison in Efficacy and Safety Between Interferon Alfacon-1 Alone and Concomitant Dosing With Ribavirin for the Treatment of Hepatitis CCompletedNo Results AvailableHepatitis CDrug: Interferon alfacon-1https://ClinicalTrials.gov/show/NCT00239252
176947176947Fractionated Dosing Study: Study to Evaluate Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid MalignanciesCompletedNo Results AvailableNon-Myeloid Malignancies|Anemia|CancerDrug: Darbepoetin alfahttps://ClinicalTrials.gov/show/NCT00239239
176948176948Electrophysiologically Guided PAcing Site Selection StudyCompletedHas ResultsSinus Arrhythmia|Atrial FibrillationProcedure: IAS pacing - study group|Procedure: IAS pacing control group|Procedure: Pacing RAA study group|Procedure: Pacing RAA control grouphttps://ClinicalTrials.gov/show/NCT00239226
176949176949Catechin Gargling for Influenza InfectionCompletedNo Results AvailableInfluenza InfectionDrug: catechin extracts (health food)https://ClinicalTrials.gov/show/NCT00239213
176950176950Lapatinib (GW572016) for Metastatic or Recurrent Squamous Cell Carcinoma EsophagusTerminatedNo Results AvailableMetastatic or Recurrent Squamous Cell Carcinoma of the EsophagusDrug: Lapatinibhttps://ClinicalTrials.gov/show/NCT00239200
176951176951A Study in Type 2 Diabetic Patients With Repeated Doses of E1 in Combination With G1CompletedNo Results AvailableType 2 DiabetesDrug: E1 and G1https://ClinicalTrials.gov/show/NCT00239187
176952176952A Multicenter Study to Evaluate the Efficacy and Safety of of Four Doses of SR147778 in Obese PatientsCompletedNo Results AvailableObesityDrug: SR147778https://ClinicalTrials.gov/show/NCT00239174
176953176953Safety and Efficacy Study of the Treatment of Kidney Infections With Short Course LevofloxacinTerminatedNo Results AvailableAcute Uncomplicated PyelonephritisDrug: Levofloxacinhttps://ClinicalTrials.gov/show/NCT00239161
176954176954A Study in Type 1 Diabetic Patients With Repeated Doses of E1 in Combination With G1CompletedNo Results AvailableType 1 DiabetesDrug: E1 and G1https://ClinicalTrials.gov/show/NCT00239148
176955176955Study to Determine the Maximum Tolerated Dose and Safety of PEP005 Topical GelCompletedNo Results AvailableKeratosisDrug: PEP005https://ClinicalTrials.gov/show/NCT00239135
176956176956Recovery Therapy TrialCompletedNo Results AvailableSchizophrenia|Psychotic Disorders|Mood DisordersBehavioral: Recovery Therapy (Cognitive Behaviour Therapy for psychosis)https://ClinicalTrials.gov/show/NCT00239122
176957176957Ziprasidone Versus Olanzapine In The Treatment Of Schizophrenia.CompletedNo Results AvailableSchizophreniaDrug: Ziprasidone|Drug: Olanzapine|Procedure: Scales|Procedure: measures of the body (Weight...)|Procedure: Serum analysishttps://ClinicalTrials.gov/show/NCT00239109
176958176958Prevention of Decompensation in Liver CirrhosisRecruitingNo Results AvailableAlcoholic Liver Cirrhosis|AscitesDrug: losartan (drug)https://ClinicalTrials.gov/show/NCT00239096
176959176959Efficacy and Safety of Enteric-Coated Mycophenolate Sodium (EC-MPS) in Renal Transplant PatientsCompletedNo Results AvailableKidney TransplantationDrug: Enteric-Coated Mycophenolate Sodium (EC-MPS)https://ClinicalTrials.gov/show/NCT00239083
176960176960Extension Study on the Safety and Efficacy of Enteric-coated Mycophenolate Sodium in Kidney Transplant RecipientsCompletedNo Results AvailableRenal TransplantationDrug: Enteric-Coated Mycophenolate Sodium (EC-MPS)https://ClinicalTrials.gov/show/NCT00239070
176961176961Study of Enteric-coated Mycophenolate Sodium Maintenance Therapy in Patients With Renal Transplant Receiving Cyclosporine Microemulsion and Steroids,CompletedNo Results AvailableMaintenance Renal TransplantationDrug: Enteric-Coated Mycophenolate Sodiumhttps://ClinicalTrials.gov/show/NCT00239057
176962176962An Open Label Study to Evaluate the Tolerability and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in Combination With Cyclosporine Microemulsion (CsA-ME) in Maintenance Renal Transplant RecipientsCompletedNo Results AvailableKidney Transplant RecipientsDrug: Enteric-coated Mycophenolate sodium (EC-MPS)https://ClinicalTrials.gov/show/NCT00239044
176963176963Study of Enteric-Coated Mycophenolate Sodium (EC-MPS) Plus Reduced-dose Cyclosporine Microemulsion (CsA-ME) Compared to EC-MPS Plus Standard Dose CsA-ME in Eldery de Novo Renal Transplant Recipients Treated With Basiliximab and Short-term SteroidsCompletedNo Results AvailableDenovo Renal TransplantationDrug: Enteric-Coated Mycophenolate Sodiumhttps://ClinicalTrials.gov/show/NCT00239031
176964176964Extension Study on the Efficacy and Safety of Enteric-coated Mycophenolate Sodium Administered in de Novo Kidney Transplant PatientsCompletedNo Results AvailableDe Novo Kidney TransplantationDrug: Enteric-Coated Mycophenolate Sodium (EC-MPS)https://ClinicalTrials.gov/show/NCT00239018
176965176965Enteric-Coated Mycophenolate Sodium on Quality of Life in Patients With Gastrointestinal Symptoms Related to Mycophenolate Mofetil Therapy After Kidney TransplantationCompletedHas ResultsRenal TransplantDrug: Enteric-Coated Mycophenolate Sodium (EC-MPS)|Drug: Mycophenolate Mofetil (MMF)https://ClinicalTrials.gov/show/NCT00239005
176966176966Study of Enteric-coated Mycophenolate Sodium (EC-MPS) With Steroid Withdrawal vs EC-MPS With Standard Steroid Regimen in de Novo Renal Transplant Recipients.CompletedNo Results AvailableKidney de Novo TransplantDrug: Enteric-coated Mycophenolate sodium (EC-MPS)https://ClinicalTrials.gov/show/NCT00238992
176967176967A Study to Investigate the Tolerability and Safety of Converting Stable Renal Transplant Recipients Who Receive Tacrolimus With or Without Corticosteroids From Mycophenolate Mofetil (MMF) to Enteric-coated Mycophenolate Sodium (EC-MPS)CompletedNo Results AvailableRenal TransplantationDrug: Enteric-Coated Mycophenolate Sodium (EC-MPS)https://ClinicalTrials.gov/show/NCT00238979
176968176968Extension Study to Assess Tolerability and Safety of Enteric-coated Mycophenolate Sodium in Renal Transplant Recipients Who Received Mycophenolate MofetilCompletedNo Results AvailableRenal TransplantationDrug: Enteric-Coated Mycophenolate Sodium (EC-MPS)https://ClinicalTrials.gov/show/NCT00238966
176969176969Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in de Novo Kidney Transplant RecipientsCompletedNo Results AvailableRenal TransplantationDrug: Enteric-Coated Mycophenolate Sodium (EC-MPS)https://ClinicalTrials.gov/show/NCT00238953
176970176970Extension Study of Enteric-coated Mycophenolate Sodium in Combination With Full Dose or Reduced Dose Cyclosporine Microemulsion in Patients With de Novo Kidney TransplantsCompletedNo Results AvailableRenal TransplantationDrug: Enteric-Coated Mycophenolate Sodium (EC-MPS)https://ClinicalTrials.gov/show/NCT00238940

* Görseller ve İçerik tekif hakkına sahip olabilir